# VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

Study · id `cardio:ct-nct04655742` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04655742](<https://clinicaltrials.gov/study/NCT04655742>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04655742

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

## Technical summary

Registry record NCT04655742. Allocation not applicable; no masking; primary purpose treatment. Start 2014-06-27 (actual); primary completion 2017-09-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT04655742, source copy `cardio:ctgov-nct04655742-2020-12-07`, retrieved 2026-10-26)
- Started: 2014-06-27 (actual) (ClinicalTrials.gov record NCT04655742, source copy `cardio:ctgov-nct04655742-2020-12-07`, retrieved 2026-10-26)
- Primary completion: 2017-09-06 (actual) (ClinicalTrials.gov record NCT04655742, source copy `cardio:ctgov-nct04655742-2020-12-07`, retrieved 2026-10-26)
- Completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT04655742, source copy `cardio:ctgov-nct04655742-2020-12-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04655742, source copy `cardio:ctgov-nct04655742-2020-12-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04655742-2020-12-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial
- Condition: Aortic Valve Stenosis
- Intervention (Device): VitaFlow™ Transcatheter Aortic Valve System
- Lead sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. (`cardio:org-shanghai-microport-cardioflow-medtech-co-ltd`)

## Provenance

Content hash: 236a8bca59d3ca4a891f6694c912f79c2b0304bd23288f7c51149144260e05d1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
